The Genuity Science established a Strategic Advisory Board in 2019 and Participant Advisory Board (PAB) in 2020. The Boards provide public and/or patient representatives with an interest in genomics research and genomic data the opportunity to provide their input into the company’s work. The company benefits from their valuable insights, and it uses these to shape its approaches and practices.
The Strategic Advisory Board comprises of six members, including one patient representative. The Board members work to an agreed terms of reference and a description of the Board member role is included. The Participant Advisory Board (PAB) comprises of ten members, all are patient representatives. The Board members were identified on the basis of expressions of interest received to a public advertisement process. The Board members work to an agreed terms of reference and a description of the Board member role is included.